Undifferentiated connective tissue disease laboratory findings: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(10 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Undifferentiated connective tissue disease}}
{{Undifferentiated connective tissue disease}}
{{CMG}} {{AE}}
{{CMG}} {{AE}}{{ADS}}


==Overview==
==Overview==
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
Laboratory findings suggestive of undifferentiated connective tissue disease include [[Leukopenia]],increased [[erythrocyte sedimentation rate]], [[C-reactive protein]], [[Antinuclear antibodies]], anti DNA antibodies, anti Ro/SSA antibodies, and anti-RNP antibodies
 
OR
 
Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
 
OR
 
[Test] is usually normal for patients with [disease name].
 
OR
 
Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
 
OR
 
There are no diagnostic laboratory findings associated with [disease name].


==Laboratory Findings==
==Laboratory Findings==
*Laboratory findings suggestive of undifferentiated connective tissue disease include:<ref name="pmid9694051">{{cite journal |vauthors=Danieli MG, Fraticelli P, Salvi A, Gabrielli A, Danieli G |title=Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD |journal=Clin. Rheumatol. |volume=17 |issue=3 |pages=195–201 |date=1998 |pmid=9694051 |doi= |url=}}</ref>
*Laboratory findings suggestive of undifferentiated connective tissue disease include:<ref name="pmid9694051">{{cite journal |vauthors=Danieli MG, Fraticelli P, Salvi A, Gabrielli A, Danieli G |title=Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD |journal=Clin. Rheumatol. |volume=17 |issue=3 |pages=195–201 |date=1998 |pmid=9694051 |doi= |url=}}</ref><ref name="pmid17110308">{{cite journal |vauthors=Mosca M, Tani C, Neri C, Baldini C, Bombardieri S |title=Undifferentiated connective tissue diseases (UCTD) |journal=Autoimmun Rev |volume=6 |issue=1 |pages=1–4 |date=November 2006 |pmid=17110308 |doi=10.1016/j.autrev.2006.03.004 |url=}}</ref><ref name="pmid12846049">{{cite journal |vauthors=Bodolay E, Csiki Z, Szekanecz Z, Ben T, Kiss E, Zeher M, Szücs G, Dankó K, Szegedi G |title=Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD) |journal=Clin. Exp. Rheumatol. |volume=21 |issue=3 |pages=313–20 |date=2003 |pmid=12846049 |doi= |url=}}</ref><ref name="pmid18328157">{{cite journal |vauthors=Ceribelli A, Cavazzana I, Franceschini F, Quinzanini M, Rizzini FL, Cattaneo R |title=Isotype switching and titer variation of anti-Ro/SSA antibodies over time in 100 patients with undifferentiated connective tissue disease (UCTD) |journal=Clin. Exp. Rheumatol. |volume=26 |issue=1 |pages=117–20 |date=2008 |pmid=18328157 |doi= |url=}}</ref><ref name="pmid24518855">{{cite journal |vauthors=Mosca M, Tani C, Vagnani S, Carli L, Bombardieri S |title=The diagnosis and classification of undifferentiated connective tissue diseases |journal=J. Autoimmun. |volume=48-49 |issue= |pages=50–2 |date=2014 |pmid=24518855 |doi=10.1016/j.jaut.2014.01.019 |url=}}</ref><ref name="pmid11875835">{{cite journal |vauthors=Bodolay E, Szegedi G |title=[Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy] |language=Hungarian |journal=Orv Hetil |volume=143 |issue=5 |pages=229–33 |date=February 2002 |pmid=11875835 |doi= |url=}}</ref><ref name="pmid11491495">{{cite journal |vauthors=Cavazzana I, Franceschini F, Belfiore N, Quinzanini M, Caporali R, Calzavara-Pinton P, Bettoni L, Brucato A, Cattaneo R, Montecucco C |title=Undifferentiated connective tissue disease with antibodies to Ro/SSa: clinical features and follow-up of 148 patients |journal=Clin. Exp. Rheumatol. |volume=19 |issue=4 |pages=403–9 |date=2001 |pmid=11491495 |doi= |url=}}</ref><ref name="LaczikSoltesz2014">{{cite journal|last1=Laczik|first1=R.|last2=Soltesz|first2=P.|last3=Szodoray|first3=P.|last4=Szekanecz|first4=Z.|last5=Kerekes|first5=G.|last6=Paragh|first6=G.|last7=Rajnavolgyi|first7=E.|last8=Abel|first8=G.|last9=Szegedi|first9=G.|last10=Bodolay|first10=E.|title=Impaired endothelial function in patients with undifferentiated connective tissue disease: a follow-up study|journal=Rheumatology|volume=53|issue=11|year=2014|pages=2035–2043|issn=1462-0324|doi=10.1093/rheumatology/keu236}}</ref>
**[[Leukopenia]]
**[[Erythrocyte Sedimentation Rate]]
**[[C-Reactive Protein]]
**[[Antinuclear antibodies]]
**[[Antinuclear antibodies]]
**Anti DNA antibodies
**Anti DNA antibodies

Latest revision as of 18:24, 30 May 2018

Undifferentiated connective tissue disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Undifferentiated connective tissue disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other imaging findings

Other diagnostic studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Undifferentiated connective tissue disease laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Undifferentiated connective tissue disease laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Undifferentiated connective tissue disease laboratory findings

CDC on Undifferentiated connective tissue disease laboratory findings

Undifferentiated connective tissue disease laboratory findings in the news

Blogs on Undifferentiated connective tissue disease laboratory findings

Directions to Hospitals Treating Undifferentiated connective tissue disease

Risk calculators and risk factors for Undifferentiated connective tissue disease laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

Overview

Laboratory findings suggestive of undifferentiated connective tissue disease include Leukopenia,increased erythrocyte sedimentation rate, C-reactive protein, Antinuclear antibodies, anti DNA antibodies, anti Ro/SSA antibodies, and anti-RNP antibodies

Laboratory Findings

References

  1. ↑ Danieli MG, Fraticelli P, Salvi A, Gabrielli A, Danieli G (1998). "Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD". Clin. Rheumatol. 17 (3): 195–201. PMID 9694051.
  2. ↑ Mosca M, Tani C, Neri C, Baldini C, Bombardieri S (November 2006). "Undifferentiated connective tissue diseases (UCTD)". Autoimmun Rev. 6 (1): 1–4. doi:10.1016/j.autrev.2006.03.004. PMID 17110308.
  3. ↑ Bodolay E, Csiki Z, Szekanecz Z, Ben T, Kiss E, Zeher M, Szücs G, Dankó K, Szegedi G (2003). "Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD)". Clin. Exp. Rheumatol. 21 (3): 313–20. PMID 12846049.
  4. ↑ Ceribelli A, Cavazzana I, Franceschini F, Quinzanini M, Rizzini FL, Cattaneo R (2008). "Isotype switching and titer variation of anti-Ro/SSA antibodies over time in 100 patients with undifferentiated connective tissue disease (UCTD)". Clin. Exp. Rheumatol. 26 (1): 117–20. PMID 18328157.
  5. ↑ Mosca M, Tani C, Vagnani S, Carli L, Bombardieri S (2014). "The diagnosis and classification of undifferentiated connective tissue diseases". J. Autoimmun. 48-49: 50–2. doi:10.1016/j.jaut.2014.01.019. PMID 24518855.
  6. ↑ Bodolay E, Szegedi G (February 2002). "[Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy]". Orv Hetil (in Hungarian). 143 (5): 229–33. PMID 11875835.
  7. ↑ Cavazzana I, Franceschini F, Belfiore N, Quinzanini M, Caporali R, Calzavara-Pinton P, Bettoni L, Brucato A, Cattaneo R, Montecucco C (2001). "Undifferentiated connective tissue disease with antibodies to Ro/SSa: clinical features and follow-up of 148 patients". Clin. Exp. Rheumatol. 19 (4): 403–9. PMID 11491495.
  8. ↑ Laczik, R.; Soltesz, P.; Szodoray, P.; Szekanecz, Z.; Kerekes, G.; Paragh, G.; Rajnavolgyi, E.; Abel, G.; Szegedi, G.; Bodolay, E. (2014). "Impaired endothelial function in patients with undifferentiated connective tissue disease: a follow-up study". Rheumatology. 53 (11): 2035–2043. doi:10.1093/rheumatology/keu236. ISSN 1462-0324.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Undifferentiated_connective_tissue_disease_laboratory_findings&oldid=1473565"